Yew Bio-Pharm Group, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 11.514 million compared to USD 3.031 million a year ago. Operating income was USD 545,274 compared to USD 219,423 a year ago. Net income was USD 377,042 compared to USD 149,006 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to USD 0 a year ago.